AstraZeneca CKD anaemia drug Roxadustat shows increased haemoglobin levels in Phase 3 trial Medical Dialogues Bureau9 Nov 2019 9:15 AM ISTNew Delhi: AstraZeneca recently presented detailed results from the Phase III OLYMPUS and ROCKIES trials showing that Roxadustat significantly...
Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia Farhat Nasim17 April 2019 9:45 AM ISTZydus Cadila Group Chairman Pankaj R Patel said this innovation has the potential to bring about a paradigm shift in the management of CKD patients...
Cipla to launch Cinacalcet Hydrochloride tablets, a generic version of Sensipar Farhat Nasim7 March 2019 9:30 AM ISTCipla said, its cinacalcet hydrochloride tablets in the strengths of 30mg, 60mg and 90mg) is generic therapeutic equivalent version of Sensipar, a...
Cipla gets USFDA nod for generic version of Renvela tablets supriya kashyap kashyap28 Oct 2017 9:18 AM ISTNew Delhi: Drug major Cipla said its subsidiary InvaGen Pharmaceuticals Inc has received final approval from the US health regulator for Sevelamer...